D-Dimer
D-dimers are specific degradation products of cross-linked fibrin. It has emerged as a promising diagnostic marker with high sensitivity to exclude acute aortic dissection.
Details：
Higher levels occur in a situation in which there is excess clotting followed by fibrinolysis. While a negative result practically rules out thrombosis, a positive impact can indicate thrombosis but does not rule out other potential causes. It is used to exclude thromboembolic disease where the probability is low. In addition, it is used in the qualification of the blood disorder disseminated intravascular coagulation (DIC).
Specification of D-dimers
Catalog No. | Product Name | Clone |
ZLA1051M | Mouse anti-human D-Dimer mAb | 2B3M |
ZLA1052M | Mouse anti-human D-Dimer mAb | 4C1M |
ZLA1052H | Humanized anti-D-Dimer mAb | 4C1H |
ZLA1053M | Mouse anti-human D-Dimer mAb | 2A10M |
ZLA1054M | Mouse anti-human D-Dimer mAb | 2G5M |
ZLA1054H | Humanized anti-D-Dimer mAb | 2G5H |
ZLA1055M | Mouse anti-human D-Dimer mAb | 2D6M |
The comparison study between Sekbio's Ab and HemosIL D-Dimer HS on ACL-TOP
Related Immunoassays
- Cardiac Markers
-
Tumor Marker
-
PGII
-
G17
- CA50
-
CA125
- CA242
-
CA15-3
- CA19-9
- CA72-4
-
Pepsinogens I (PGI)
-
Human Epididymis 4 (HE4)
- Prostate-Specific Antigen (PSA)
- Squamous Cell Carcinoma (SCC)
- Neuron-Specific Enolase (NSE)
- Cytokeratin 19 Fragment (CYFRA21-1)
- Human Progastrin-releasing Peptide (ProGRP Tumor Marker)
- Protein Induced by Vitamin K Absence or Antagonist-II (PIVKA II Tumor Marker)
- Alpha-fetoprotein(AFP)
-
CEA
-
Human Chitinase 3-like 1
-
PGII
- Inflammatory Marker
- Infectious Disease
- Hormones
- Thyroid Function
- Glucose Metabolism
- Bone Marker
- Others
-
Heterophilic Blocking Reagent
- Animal Diagnostics
